🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Germline Sequencing of DNA Damage Repair Genes in Two Hereditary Prostate Cancer Cohorts Reveals New Disease Risk-Associated Gene Variants

Cancers(2024)10.3390/cancers16132482Source: DataRank Database

Germline Sequencing of DNA Damage Repair Genes in Two Hereditary Prostate Cancer Cohorts Reveals New Disease Risk-Associated Gene Variants is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Cite:

Linked data & code

refsnp nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.00)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

James R. Marthick,Sionne E. M. Lucas ORCID,Kelsie Raspin ORCID,Annette Banks ORCID,Janet L. Stanford

Live enrichment

PubMed:39001544 PMC:PMC11240467 OpenAlex:https://openalex.org/W4400419199

Cancer Council Tasmania and IMPACT Perpetual Trustees

Grant: IPAP20210253

Cancer Council Tasmania and IMPACT Perpetual Trustees

Grant: NA

Cancer Council Tasmania and IMPACT Perpetual Trustees

Grant: P30 CA015704

Cancer Council Tasmania and IMPACT Perpetual Trustees

Grant: R01 CA080122

Cancer Council Tasmania and IMPACT Perpetual Trustees

Grant: U01 CA089600

Cancer Council Tasmania and IMPACT Perpetual Trustees

Grant: K05 CA17514

National Institutes of Health

Grant: 2R01CA080122-06

Genetic Epidemiology of Prostate Cancer

National Institutes of Health

Grant: 3P30CA015704-48S1

Cancer Center Support Grant

National Institutes of Health

Grant: 5U01CA089600-04

Prostate Cancer Susceptibility: The ICPCG Study

FWCI

0.00

Citation Percentile

0.2%

Influential Citations

1

goldLicense: cc-by

journalhttps://doi.org/10.3390/cancers16132482

publisherhttps://doi.org/10.3390/cancers16132482

publisherhttps://www.mdpi.com/2072-6694/16/13/2482/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39001544

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11240467

Fields of Study

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentPARP inhibition in cancer therapyMedicineBiology03 medical and health sciences0302 clinical medicine

Keywords

MUTYHGeneDiseaseExome sequencingMedicineProstate cancerGermlineCancerExomeGeneticsBioinformaticsBiologyInternal medicineGermline mutationMutationDNA repairGenetic susceptibilityGermline VariantsRare High-risk GenesArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being